These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26174900)

  • 21. Pathogenesis and mechanisms of antibody-mediated hemolysis.
    Flegel WA
    Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safeguarding immune globulin recipients against hemolysis: what do we know and where do we go?
    Scott DE; Epstein JS
    Transfusion; 2015 Jul; 55 Suppl 2():S122-6. PubMed ID: 26174890
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of immune regulation by IVIG.
    Ballow M
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):509-15. PubMed ID: 25337683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease.
    Comenzo RL; Malachowski ME; Meissner HC; Fulton DR; Berkman EM
    J Pediatr; 1992 Jun; 120(6):926-8. PubMed ID: 1593353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
    Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA
    Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editors' Notes.
    Klein HG; Schreiber GB
    Transfusion; 2015 Jul; 55 Suppl 2():S1. PubMed ID: 26174886
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-A and anti-B: what are they and where do they come from?
    Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of a monocyte monolayer assay in the assessment of intravenous immunoglobulin-associated hemolysis.
    Tong TN; Blacquiere M; Sakac D; Burke-Murphy E; Yi Q; Callum J; Cserti-Gazdewich C; Parmar N; Shehata N; Pavenski K; Lau W; Lin Y; Lieberman L; Branch DR; Pendergrast J
    Transfusion; 2020 Dec; 60(12):3010-3018. PubMed ID: 33091964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia.
    Rink BD; Gonik B; Chmait RH; O'Shaughnessy R
    Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):471-3. PubMed ID: 23344412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.
    Winiecki S; Baer B; Chege W; Jankosky C; Mintz P; Baker M; Woodworth T; Nguyen M
    Transfusion; 2015 Jul; 55 Suppl 2():S28-35. PubMed ID: 26174895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic events after the administration of lyophilized versus liquid immune globulin: an analysis of a single manufacturer's safety database.
    Berg R; Jacob D; Fuellenhals E
    Transfusion; 2015 Aug; 55(8):1847-54. PubMed ID: 25867204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.
    Jordan SC; Toyoda M; Vo AA
    Expert Rev Clin Immunol; 2011 May; 7(3):341-8. PubMed ID: 21595600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemolytic adverse effects of intravenous immunoglobulin: modeling predicts risk reduction with anti-A/B immunoaffinity chromatography and to a lesser extent with anti-A donor screening.
    Mallick R; Hubsch A; Barnes DG
    Transfusion; 2018 Dec; 58(12):2752-2756. PubMed ID: 30284263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial.
    Akman AO; Kara FK; Koksal T; Cakir BC; Karagol C; Sayli T
    Transfus Apher Sci; 2017 Aug; 56(4):531-534. PubMed ID: 28818402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.